Cognition Therapeutics (CGTX) Short Interest Ratio & Short Volume → Don’t expose yourself to stocks during the week (From DTI) (Ad) Free CGTX Stock Alerts $1.84 -0.06 (-3.16%) (As of 04/18/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Cognition Therapeutics Short Interest DataCurrent Short Volume150,200 sharesPrevious Short Volume228,100 sharesChange Vs. Previous Month-34.15%Dollar Volume Sold Short$273,364.00Short Interest Ratio / Days to Cover0.7Last Record DateMarch 31, 2024Outstanding Shares39,000,000 sharesFloat Size28,250,000 sharesShort Percent of Float0.53%Today's Trading Volume99,177 sharesAverage Trading Volume135,701 sharesToday's Volume Vs. Average73% Short Selling Cognition Therapeutics ? Sign up to receive the latest short interest report for Cognition Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCGTX Short Interest Over TimeCGTX Days to Cover Over TimeCGTX Percentage of Float Shorted Over Time Ad Insiders ExposedThis consistently signaled gains of 453%... 610%... and even 1036%...It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.Register for the imminent briefing here. Cognition Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2024150,200 shares $273,364.00 -34.2%0.5%0.7 $1.82 3/15/2024228,100 shares $415,142.00 +79.9%1.0%1.1 $1.82 2/29/2024126,800 shares $262,476.00 +26.2%0.6%0.5 $2.07 2/15/2024100,500 shares $198,990.00 -30.9%0.5%0.5 $1.98 1/31/2024145,400 shares $330,058.00 +24.0%0.7%0.8 $2.27 1/15/2024117,300 shares $236,946.00 +65.0%0.5%0.6 $2.02 Get the Latest News and Ratings for CGTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cognition Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/31/202371,100 shares $131,535.00 -52.9%0.3%0.4 $1.85 12/15/2023150,900 shares $307,836.00 -23.6%0.7%0.9 $2.04 11/30/2023197,500 shares $219,225.00 -17.8%0.9%1.7 $1.11 11/15/2023240,200 shares $252,210.00 -19.1%1.1%2.4 $1.05 10/31/2023296,800 shares $332,416.00 +368.9%1.3%3.1 $1.12 10/15/202363,300 shares $70,896.00 -34.3%0.3%1.6 $1.12 9/30/202396,300 shares $138,672.00 +16.3%0.4%2.3 $1.44 9/15/202382,800 shares $104,328.00 -4.5%0.4%0.7 $1.26 8/31/202386,700 shares $134,385.00 +5.0%0.4%0.7 $1.55 8/15/202382,600 shares $123,074.00 -21.1%0.4%0.5 $1.49 7/31/2023104,700 shares $173,802.00 -36.2%0.5%0.6 $1.66 7/15/2023164,100 shares $283,893.00 -33.7%0.8%1 $1.73 6/30/2023247,600 shares $453,108.00 +131.2%1.2%1.6 $1.83 6/15/2023107,100 shares $320,229.00 +75.0%0.5%1.2 $2.99 5/31/202361,200 shares $125,460.00 -4.8%0.3%0.7 $2.05 5/15/202364,300 shares $109,953.00 -8.8%0.3%0.9 $1.71 4/30/202370,500 shares $125,490.00 -15.0%0.3%1.1 $1.78 4/15/202382,900 shares $147,562.00 -35.7%0.4%1.2 $1.78 3/31/2023128,900 shares $255,222.00 +56.6%0.6%1.7 $1.98 3/15/202382,300 shares $135,795.00 -3.1%0.4%1.1 $1.65 2/28/202384,900 shares $135,840.00 +43.9%0.5%0.9 $1.60 2/15/202359,000 shares $110,330.00 +1.0%0.4%0.3 $1.87 1/31/202358,400 shares $115,048.00 -34.9%0.3%0.3 $1.97 1/15/202389,700 shares $199,134.00 -16.8%0.5%0.5 $2.22 12/30/2022107,800 shares $226,380.00 -32.9%0.7%0.6 $2.10 12/15/2022160,600 shares $420,772.00 -49.3%1.1%0.8 $2.62 11/30/2022316,500 shares $1.11 million +136.2%2.1%1.6 $3.51 11/15/2022134,000 shares $194,300.00 +116.1%0.9%1.1 $1.45 10/31/202262,000 shares $110,360.00 +98.1%0.4%0.7 $1.78 10/15/202231,300 shares $56,966.00 -40.8%0.2%0.1 $1.82 9/30/202252,900 shares $100,510.00 +8.4%0.3%0.1 $1.90 9/15/202248,800 shares $91,256.00 +15.4%0.4%0.1 $1.87 8/31/202242,300 shares $86,715.00 +10.7%0.3%0.1 $2.05 8/15/202238,200 shares $76,400.00 +144.9%0.3%0.1 $2.00Don’t expose yourself to stocks during the week (Ad)The S&P 500 just crossed below the 200 day moving average… The Nasdaq is bleeding out… Are we headed for a recession?! If you’ve been in the stock market the last few months, it hasn’t been fun… But what if I told you there was a way to target “BONUS” income just by doing a unique type of trade over the weekend? When the markets are closed. And volatility is minimal.Click here and I’ll give you all the details. CGTX Short Interest - Frequently Asked Questions What is Cognition Therapeutics' current short interest? Short interest is the volume of Cognition Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 150,200 shares of CGTX short. 0.53% of Cognition Therapeutics' shares are currently sold short. Learn More on Cognition Therapeutics' current short interest. What is a good short interest ratio for Cognition Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CGTX shares currently have a short interest ratio of 1.0. Learn More on Cognition Therapeutics's short interest ratio. What is a good short interest percentage for Cognition Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.53% of Cognition Therapeutics' floating shares are currently sold short. Is Cognition Therapeutics' short interest increasing or decreasing? Cognition Therapeutics saw a decline in short interest in the month of March. As of March 31st, there was short interest totaling 150,200 shares, a decline of 34.2% from the previous total of 228,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Cognition Therapeutics' float size? Cognition Therapeutics currently has issued a total of 39,000,000 shares. Some of Cognition Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cognition Therapeutics currently has a public float of 28,250,000 shares. How does Cognition Therapeutics' short interest compare to its competitors? 0.53% of Cognition Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Cognition Therapeutics: Gritstone bio, Inc. (9.40%), Semper Paratus Acquisition Co. (0.25%), Passage Bio, Inc. (3.57%), Elutia Inc. (0.14%), Instil Bio, Inc. (0.22%), Athira Pharma, Inc. (2.86%), Cidara Therapeutics, Inc. (0.22%), Atara Biotherapeutics, Inc. (9.41%), Entera Bio Ltd. (0.31%), Turnstone Biologics Corp. (4.74%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Cognition Therapeutics stock? Short selling CGTX is an investing strategy that aims to generate trading profit from Cognition Therapeutics as its price is falling. CGTX shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cognition Therapeutics? A short squeeze for Cognition Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CGTX, which in turn drives the price of the stock up even further. How often is Cognition Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CGTX, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: GRTS Short Interest LGST Short Interest PASG Short Interest ELUT Short Interest TIL Short Interest ATHA Short Interest CDTX Short Interest ATRA Short Interest ENTX Short Interest TSBX Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CGTX) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceHow Biden has already won 2024Porter & CompanyUrgent alert: open this for a huge profit potentialTimothy Sykes